Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
B.4.8EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
A.2.4EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.41EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.137EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.446EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AY.76 (Delta)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.398EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.163EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
P.3 (Theta)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.2.38.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XAVEWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BE.1.4.4EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBC.1.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BM.4.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BF.20EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.2.77EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
CP.1.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.2.60EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.2.9.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.2.11EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.2.3.15EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.5.6.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.5.1.35EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1.45EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.177.31EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.160.26EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AY.39.1.2 (Delta)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AY.4.15 (Delta)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.2.75.10EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.36.21EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.134EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AY.39.1.3 (Delta)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
C.38EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBC.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
Q.2 (Alpha)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BL.1.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
M.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
C.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AY.82 (Delta)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
A.30EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.36.35EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AY.23.1 (Delta)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.466.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.213EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
FC.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BY.1.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BF.7.17EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AY.123 (Delta)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BQ.1.27EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BQ.1.1.71EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used